nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—BTK—hematologic cancer	0.125	0.662	CbGaD
Mitoxantrone—Topoisomerase Inhibitors—Daunorubicin—hematologic cancer	0.105	0.226	CiPCiCtD
Mitoxantrone—Topoisomerase Inhibitors—Teniposide—hematologic cancer	0.0896	0.192	CiPCiCtD
Mitoxantrone—Topoisomerase Inhibitors—Idarubicin—hematologic cancer	0.0798	0.171	CiPCiCtD
Mitoxantrone—Topoisomerase Inhibitors—Irinotecan—hematologic cancer	0.0679	0.145	CiPCiCtD
Mitoxantrone—Topoisomerase Inhibitors—Etoposide—hematologic cancer	0.0533	0.114	CiPCiCtD
Mitoxantrone—Topoisomerase Inhibitors—Epirubicin—hematologic cancer	0.0367	0.0786	CiPCiCtD
Mitoxantrone—Topoisomerase Inhibitors—Doxorubicin—hematologic cancer	0.0339	0.0727	CiPCiCtD
Mitoxantrone—TOP2A—hematologic cancer	0.0324	0.171	CbGaD
Mitoxantrone—BTK—Dasatinib—hematologic cancer	0.0299	0.139	CbGbCtD
Mitoxantrone—ABCG2—hematologic cancer	0.0221	0.117	CbGaD
Mitoxantrone—CYP1B1—Procarbazine—hematologic cancer	0.0144	0.0668	CbGbCtD
Mitoxantrone—TOP2A—Idarubicin—hematologic cancer	0.0139	0.0648	CbGbCtD
Mitoxantrone—SLC47A1—Imatinib—hematologic cancer	0.0123	0.0571	CbGbCtD
Mitoxantrone—TOP2A—Daunorubicin—hematologic cancer	0.00987	0.0459	CbGbCtD
Mitoxantrone—ABCB1—hematologic cancer	0.0092	0.0488	CbGaD
Mitoxantrone—TOP2A—Teniposide—hematologic cancer	0.00857	0.0399	CbGbCtD
Mitoxantrone—ABCC1—Idarubicin—hematologic cancer	0.00773	0.0359	CbGbCtD
Mitoxantrone—CYP1B1—Daunorubicin—hematologic cancer	0.0077	0.0358	CbGbCtD
Mitoxantrone—ABCG2—Clofarabine—hematologic cancer	0.00624	0.029	CbGbCtD
Mitoxantrone—ABCC1—Daunorubicin—hematologic cancer	0.00547	0.0254	CbGbCtD
Mitoxantrone—TOP2A—Epirubicin—hematologic cancer	0.00485	0.0226	CbGbCtD
Mitoxantrone—CYP1B1—Dasatinib—hematologic cancer	0.00474	0.022	CbGbCtD
Mitoxantrone—TOP2A—Etoposide—hematologic cancer	0.00378	0.0176	CbGbCtD
Mitoxantrone—ABCG2—Daunorubicin—hematologic cancer	0.00366	0.017	CbGbCtD
Mitoxantrone—ABCG2—Teniposide—hematologic cancer	0.00318	0.0148	CbGbCtD
Mitoxantrone—ABCG2—Cladribine—hematologic cancer	0.00305	0.0142	CbGbCtD
Mitoxantrone—ABCG2—Imatinib—hematologic cancer	0.0028	0.013	CbGbCtD
Mitoxantrone—ABCC1—Epirubicin—hematologic cancer	0.00269	0.0125	CbGbCtD
Mitoxantrone—ABCC1—Irinotecan—hematologic cancer	0.00262	0.0122	CbGbCtD
Mitoxantrone—TOP2A—Doxorubicin—hematologic cancer	0.00258	0.012	CbGbCtD
Mitoxantrone—ABCG2—Nilotinib—hematologic cancer	0.00255	0.0118	CbGbCtD
Mitoxantrone—CYP1B1—Dexamethasone—hematologic cancer	0.00243	0.0113	CbGbCtD
Mitoxantrone—CYP2E1—Thalidomide—hematologic cancer	0.00238	0.011	CbGbCtD
Mitoxantrone—ABCC1—Vinblastine—hematologic cancer	0.00233	0.0108	CbGbCtD
Mitoxantrone—ABCC1—Vincristine—hematologic cancer	0.00229	0.0106	CbGbCtD
Mitoxantrone—ABCG2—Dasatinib—hematologic cancer	0.00225	0.0105	CbGbCtD
Mitoxantrone—ABCB1—Lenalidomide—hematologic cancer	0.00225	0.0105	CbGbCtD
Mitoxantrone—ABCC1—Etoposide—hematologic cancer	0.0021	0.00974	CbGbCtD
Mitoxantrone—CYP2E1—Dacarbazine—hematologic cancer	0.00204	0.0095	CbGbCtD
Mitoxantrone—CYP1B1—Doxorubicin—hematologic cancer	0.00201	0.00936	CbGbCtD
Mitoxantrone—ABCG2—Irinotecan—hematologic cancer	0.00175	0.00814	CbGbCtD
Mitoxantrone—ABCG2—Vincristine—hematologic cancer	0.00153	0.00712	CbGbCtD
Mitoxantrone—ABCC1—Doxorubicin—hematologic cancer	0.00143	0.00665	CbGbCtD
Mitoxantrone—ABCG2—Cisplatin—hematologic cancer	0.00143	0.00664	CbGbCtD
Mitoxantrone—ABCG2—Etoposide—hematologic cancer	0.0014	0.00652	CbGbCtD
Mitoxantrone—ABCC1—Methotrexate—hematologic cancer	0.00138	0.00644	CbGbCtD
Mitoxantrone—CYP3A4—Bexarotene—hematologic cancer	0.00135	0.00627	CbGbCtD
Mitoxantrone—ABCB1—Daunorubicin—hematologic cancer	0.00132	0.00614	CbGbCtD
Mitoxantrone—ABCB1—Alitretinoin—hematologic cancer	0.00129	0.00601	CbGbCtD
Mitoxantrone—CYP3A4—Lomustine—hematologic cancer	0.00125	0.00583	CbGbCtD
Mitoxantrone—CYP3A4—Busulfan—hematologic cancer	0.00125	0.00583	CbGbCtD
Mitoxantrone—ABCG2—Dexamethasone—hematologic cancer	0.00115	0.00536	CbGbCtD
Mitoxantrone—CYP3A4—Thiotepa—hematologic cancer	0.00112	0.0052	CbGbCtD
Mitoxantrone—ABCB1—Imatinib—hematologic cancer	0.00101	0.0047	CbGbCtD
Mitoxantrone—CYP2E1—Etoposide—hematologic cancer	0.001	0.00465	CbGbCtD
Mitoxantrone—ABCG2—Doxorubicin—hematologic cancer	0.000956	0.00445	CbGbCtD
Mitoxantrone—ABCG2—Methotrexate—hematologic cancer	0.000926	0.00431	CbGbCtD
Mitoxantrone—ABCB1—Nilotinib—hematologic cancer	0.000918	0.00427	CbGbCtD
Mitoxantrone—ABCB1—Vinorelbine—hematologic cancer	0.000911	0.00424	CbGbCtD
Mitoxantrone—BTK—hematopoietic system—hematologic cancer	0.000902	0.0684	CbGeAlD
Mitoxantrone—CYP3A4—Methoxsalen—hematologic cancer	0.000869	0.00404	CbGbCtD
Mitoxantrone—CYP3A4—Bortezomib—hematologic cancer	0.000826	0.00384	CbGbCtD
Mitoxantrone—CYP2E1—Dexamethasone—hematologic cancer	0.000822	0.00382	CbGbCtD
Mitoxantrone—ABCB1—Dasatinib—hematologic cancer	0.000812	0.00377	CbGbCtD
Mitoxantrone—CYP3A4—Daunorubicin—hematologic cancer	0.000791	0.00368	CbGbCtD
Mitoxantrone—PIM1—hematopoietic system—hematologic cancer	0.000781	0.0592	CbGeAlD
Mitoxantrone—ABCB1—Betamethasone—hematologic cancer	0.000715	0.00332	CbGbCtD
Mitoxantrone—ABCB1—Gemcitabine—hematologic cancer	0.000708	0.00329	CbGbCtD
Mitoxantrone—ABCB1—Prednisolone—hematologic cancer	0.000705	0.00328	CbGbCtD
Mitoxantrone—CYP3A4—Cytarabine—hematologic cancer	0.000697	0.00324	CbGbCtD
Mitoxantrone—CYP3A4—Teniposide—hematologic cancer	0.000687	0.00319	CbGbCtD
Mitoxantrone—ABCB1—Prednisone—hematologic cancer	0.000666	0.0031	CbGbCtD
Mitoxantrone—CYP3A4—Ifosfamide—hematologic cancer	0.000634	0.00295	CbGbCtD
Mitoxantrone—ABCB1—Irinotecan—hematologic cancer	0.000631	0.00294	CbGbCtD
Mitoxantrone—CYP3A4—Imatinib—hematologic cancer	0.000606	0.00282	CbGbCtD
Mitoxantrone—BTK—blood—hematologic cancer	0.000598	0.0453	CbGeAlD
Mitoxantrone—BTK—bone marrow—hematologic cancer	0.000578	0.0438	CbGeAlD
Mitoxantrone—CYP3A4—Ruxolitinib—hematologic cancer	0.00057	0.00265	CbGbCtD
Mitoxantrone—ABCB1—Vinblastine—hematologic cancer	0.000561	0.00261	CbGbCtD
Mitoxantrone—ABCB1—Vincristine—hematologic cancer	0.000552	0.00257	CbGbCtD
Mitoxantrone—CYP3A4—Nilotinib—hematologic cancer	0.00055	0.00256	CbGbCtD
Mitoxantrone—CYP3A4—Vinorelbine—hematologic cancer	0.000546	0.00254	CbGbCtD
Mitoxantrone—BTK—lung—hematologic cancer	0.000524	0.0397	CbGeAlD
Mitoxantrone—PIM1—blood—hematologic cancer	0.000518	0.0392	CbGeAlD
Mitoxantrone—ABCB1—Cisplatin—hematologic cancer	0.000515	0.00239	CbGbCtD
Mitoxantrone—ABCB1—Etoposide—hematologic cancer	0.000506	0.00235	CbGbCtD
Mitoxantrone—PIM1—bone marrow—hematologic cancer	0.000501	0.038	CbGeAlD
Mitoxantrone—CYP3A4—Triamcinolone—hematologic cancer	0.000499	0.00232	CbGbCtD
Mitoxantrone—BTK—testis—hematologic cancer	0.000494	0.0375	CbGeAlD
Mitoxantrone—CYP3A4—Dasatinib—hematologic cancer	0.000486	0.00226	CbGbCtD
Mitoxantrone—PIM1—lung—hematologic cancer	0.000454	0.0344	CbGeAlD
Mitoxantrone—CYP3A4—Betamethasone—hematologic cancer	0.000428	0.00199	CbGbCtD
Mitoxantrone—PIM1—testis—hematologic cancer	0.000428	0.0325	CbGeAlD
Mitoxantrone—CYP3A4—Prednisolone—hematologic cancer	0.000422	0.00196	CbGbCtD
Mitoxantrone—SLC47A1—hematopoietic system—hematologic cancer	0.000419	0.0317	CbGeAlD
Mitoxantrone—ABCB1—Dexamethasone—hematologic cancer	0.000416	0.00193	CbGbCtD
Mitoxantrone—CYP3A4—Prednisone—hematologic cancer	0.000399	0.00186	CbGbCtD
Mitoxantrone—CYP3A4—Irinotecan—hematologic cancer	0.000378	0.00176	CbGbCtD
Mitoxantrone—BTK—lymph node—hematologic cancer	0.000358	0.0272	CbGeAlD
Mitoxantrone—ABCB1—Doxorubicin—hematologic cancer	0.000345	0.0016	CbGbCtD
Mitoxantrone—CYP3A4—Vinblastine—hematologic cancer	0.000336	0.00156	CbGbCtD
Mitoxantrone—ABCB1—Methotrexate—hematologic cancer	0.000334	0.00155	CbGbCtD
Mitoxantrone—CYP3A4—Vincristine—hematologic cancer	0.000331	0.00154	CbGbCtD
Mitoxantrone—SLC47A1—gonad—hematologic cancer	0.000318	0.0241	CbGeAlD
Mitoxantrone—PIM1—lymph node—hematologic cancer	0.00031	0.0235	CbGeAlD
Mitoxantrone—CYP1B1—hematopoietic system—hematologic cancer	0.000307	0.0233	CbGeAlD
Mitoxantrone—TOP2A—blood—hematologic cancer	0.000304	0.023	CbGeAlD
Mitoxantrone—CYP3A4—Etoposide—hematologic cancer	0.000303	0.00141	CbGbCtD
Mitoxantrone—TOP2A—bone marrow—hematologic cancer	0.000294	0.0223	CbGeAlD
Mitoxantrone—SLC47A1—blood—hematologic cancer	0.000277	0.021	CbGeAlD
Mitoxantrone—TOP2A—lung—hematologic cancer	0.000266	0.0202	CbGeAlD
Mitoxantrone—TOP2A—testis—hematologic cancer	0.000251	0.019	CbGeAlD
Mitoxantrone—CYP3A4—Dexamethasone—hematologic cancer	0.000249	0.00116	CbGbCtD
Mitoxantrone—SLC47A1—lung—hematologic cancer	0.000243	0.0184	CbGeAlD
Mitoxantrone—CYP1B1—gonad—hematologic cancer	0.000233	0.0177	CbGeAlD
Mitoxantrone—SLC47A1—testis—hematologic cancer	0.000229	0.0174	CbGeAlD
Mitoxantrone—CYP3A4—Doxorubicin—hematologic cancer	0.000207	0.000961	CbGbCtD
Mitoxantrone—CYP1B1—blood—hematologic cancer	0.000203	0.0154	CbGeAlD
Mitoxantrone—CYP2E1—hematopoietic system—hematologic cancer	0.000198	0.015	CbGeAlD
Mitoxantrone—ABCC1—blood—hematologic cancer	0.000183	0.0139	CbGeAlD
Mitoxantrone—TOP2A—lymph node—hematologic cancer	0.000182	0.0138	CbGeAlD
Mitoxantrone—CYP1B1—lung—hematologic cancer	0.000178	0.0135	CbGeAlD
Mitoxantrone—CYP1B1—testis—hematologic cancer	0.000168	0.0127	CbGeAlD
Mitoxantrone—SLC47A1—lymph node—hematologic cancer	0.000166	0.0126	CbGeAlD
Mitoxantrone—ABCC1—lung—hematologic cancer	0.00016	0.0122	CbGeAlD
Mitoxantrone—CYP3A4—hematopoietic system—hematologic cancer	0.000159	0.0121	CbGeAlD
Mitoxantrone—ABCG2—blood—hematologic cancer	0.000151	0.0115	CbGeAlD
Mitoxantrone—ABCC1—testis—hematologic cancer	0.000151	0.0115	CbGeAlD
Mitoxantrone—ABCG2—bone marrow—hematologic cancer	0.000146	0.0111	CbGeAlD
Mitoxantrone—ABCG2—lung—hematologic cancer	0.000133	0.0101	CbGeAlD
Mitoxantrone—CYP2E1—blood—hematologic cancer	0.000131	0.00993	CbGeAlD
Mitoxantrone—ABCG2—testis—hematologic cancer	0.000125	0.00949	CbGeAlD
Mitoxantrone—CYP1B1—lymph node—hematologic cancer	0.000122	0.00924	CbGeAlD
Mitoxantrone—CYP2E1—lung—hematologic cancer	0.000115	0.00871	CbGeAlD
Mitoxantrone—ABCB1—hematopoietic system—hematologic cancer	0.000113	0.00854	CbGeAlD
Mitoxantrone—ABCC1—lymph node—hematologic cancer	0.00011	0.00831	CbGeAlD
Mitoxantrone—CYP2E1—testis—hematologic cancer	0.000108	0.00822	CbGeAlD
Mitoxantrone—CYP3A4—blood—hematologic cancer	0.000105	0.00799	CbGeAlD
Mitoxantrone—ABCG2—lymph node—hematologic cancer	9.08e-05	0.00688	CbGeAlD
Mitoxantrone—TOP2A—Nilotinib—Imatinib—hematologic cancer	8.61e-05	0.0778	CbGdCrCtD
Mitoxantrone—ABCB1—gonad—hematologic cancer	8.57e-05	0.00649	CbGeAlD
Mitoxantrone—ABCB1—blood—hematologic cancer	7.46e-05	0.00566	CbGeAlD
Mitoxantrone—ABCB1—bone marrow—hematologic cancer	7.22e-05	0.00548	CbGeAlD
Mitoxantrone—ABCB1—lung—hematologic cancer	6.54e-05	0.00496	CbGeAlD
Mitoxantrone—ABCB1—testis—hematologic cancer	6.17e-05	0.00468	CbGeAlD
Mitoxantrone—TOP2A—Topotecan—Irinotecan—hematologic cancer	4.78e-05	0.0431	CbGdCrCtD
Mitoxantrone—TOP2A—Etoposide—Teniposide—hematologic cancer	4.75e-05	0.0429	CbGdCrCtD
Mitoxantrone—ABCB1—lymph node—hematologic cancer	4.48e-05	0.00339	CbGeAlD
Mitoxantrone—TOP2A—Vindesine—Vinorelbine—hematologic cancer	4.27e-05	0.0386	CbGdCrCtD
Mitoxantrone—TOP2A—Podofilox—Teniposide—hematologic cancer	3.62e-05	0.0327	CbGdCrCtD
Mitoxantrone—TOP2A—Vindesine—Vincristine—hematologic cancer	3.41e-05	0.0308	CbGdCrCtD
Mitoxantrone—TOP2A—Vindesine—Vinblastine—hematologic cancer	3.41e-05	0.0308	CbGdCrCtD
Mitoxantrone—TOP2A—Floxuridine—Pentostatin—hematologic cancer	3.29e-05	0.0297	CbGdCrCtD
Mitoxantrone—TOP2A—Idarubicin—Daunorubicin—hematologic cancer	3.23e-05	0.0291	CbGdCrCtD
Mitoxantrone—TOP2A—Epirubicin—Daunorubicin—hematologic cancer	3.23e-05	0.0291	CbGdCrCtD
Mitoxantrone—TOP2A—Doxorubicin—Daunorubicin—hematologic cancer	3.23e-05	0.0291	CbGdCrCtD
Mitoxantrone—TOP2A—Menadione—Thalidomide—hematologic cancer	2.74e-05	0.0248	CbGdCrCtD
Mitoxantrone—TOP2A—Cladribine—Pentostatin—hematologic cancer	2.49e-05	0.0225	CbGdCrCtD
Mitoxantrone—TOP2A—Doxorubicin—Idarubicin—hematologic cancer	2.45e-05	0.0221	CbGdCrCtD
Mitoxantrone—TOP2A—Daunorubicin—Idarubicin—hematologic cancer	2.45e-05	0.0221	CbGdCrCtD
Mitoxantrone—TOP2A—Epirubicin—Idarubicin—hematologic cancer	2.45e-05	0.0221	CbGdCrCtD
Mitoxantrone—TOP2A—Vincristine—Vinorelbine—hematologic cancer	2.3e-05	0.0208	CbGdCrCtD
Mitoxantrone—TOP2A—Cladribine—Clofarabine—hematologic cancer	2.22e-05	0.0201	CbGdCrCtD
Mitoxantrone—TOP2A—Vinorelbine—Vincristine—hematologic cancer	2.15e-05	0.0195	CbGdCrCtD
Mitoxantrone—TOP2A—Vinorelbine—Vinblastine—hematologic cancer	2.15e-05	0.0195	CbGdCrCtD
Mitoxantrone—TOP2A—Podofilox—Etoposide—hematologic cancer	2.15e-05	0.0194	CbGdCrCtD
Mitoxantrone—TOP2A—Teniposide—Etoposide—hematologic cancer	2.15e-05	0.0194	CbGdCrCtD
Mitoxantrone—TOP2A—Cladribine—Nelarabine—hematologic cancer	2.09e-05	0.0189	CbGdCrCtD
Mitoxantrone—TOP2A—Floxuridine—Cladribine—hematologic cancer	1.98e-05	0.0179	CbGdCrCtD
Mitoxantrone—TOP2A—Clofarabine—Nelarabine—hematologic cancer	1.93e-05	0.0174	CbGdCrCtD
Mitoxantrone—TOP2A—Vinblastine—Vinorelbine—hematologic cancer	1.85e-05	0.0167	CbGdCrCtD
Mitoxantrone—TOP2A—Vincristine—Vinblastine—hematologic cancer	1.84e-05	0.0166	CbGdCrCtD
Mitoxantrone—TOP2A—Cytarabine—Clofarabine—hematologic cancer	1.75e-05	0.0158	CbGdCrCtD
Mitoxantrone—TOP2A—Cytarabine—Nelarabine—hematologic cancer	1.64e-05	0.0148	CbGdCrCtD
Mitoxantrone—TOP2A—Cladribine—Fludarabine—hematologic cancer	1.63e-05	0.0147	CbGdCrCtD
Mitoxantrone—TOP2A—Clofarabine—Fludarabine—hematologic cancer	1.51e-05	0.0136	CbGdCrCtD
Mitoxantrone—TOP2A—Vinblastine—Vincristine—hematologic cancer	1.48e-05	0.0134	CbGdCrCtD
Mitoxantrone—TOP2A—Clofarabine—Cytarabine—hematologic cancer	1.42e-05	0.0129	CbGdCrCtD
Mitoxantrone—TOP2A—Azacitidine—Pentostatin—hematologic cancer	1.41e-05	0.0127	CbGdCrCtD
Mitoxantrone—TOP2A—Clofarabine—Cladribine—hematologic cancer	1.39e-05	0.0125	CbGdCrCtD
Mitoxantrone—TOP2A—Gemcitabine—Cytarabine—hematologic cancer	1.32e-05	0.0119	CbGdCrCtD
Mitoxantrone—TOP2A—Cytarabine—Fludarabine—hematologic cancer	1.28e-05	0.0116	CbGdCrCtD
Mitoxantrone—TOP2A—Azacitidine—Clofarabine—hematologic cancer	1.25e-05	0.0113	CbGdCrCtD
Mitoxantrone—TOP2A—Cytarabine—Gemcitabine—hematologic cancer	1.21e-05	0.0109	CbGdCrCtD
Mitoxantrone—TOP2A—Azacitidine—Nelarabine—hematologic cancer	1.18e-05	0.0106	CbGdCrCtD
Mitoxantrone—TOP2A—Doxorubicin—Epirubicin—hematologic cancer	1.12e-05	0.0101	CbGdCrCtD
Mitoxantrone—TOP2A—Daunorubicin—Epirubicin—hematologic cancer	1.12e-05	0.0101	CbGdCrCtD
Mitoxantrone—TOP2A—Idarubicin—Epirubicin—hematologic cancer	1.12e-05	0.0101	CbGdCrCtD
Mitoxantrone—TOP2A—Epirubicin—Doxorubicin—hematologic cancer	1.04e-05	0.00938	CbGdCrCtD
Mitoxantrone—TOP2A—Idarubicin—Doxorubicin—hematologic cancer	1.04e-05	0.00938	CbGdCrCtD
Mitoxantrone—TOP2A—Daunorubicin—Doxorubicin—hematologic cancer	1.04e-05	0.00938	CbGdCrCtD
Mitoxantrone—TOP2A—Azacitidine—Fludarabine—hematologic cancer	9.19e-06	0.0083	CbGdCrCtD
Mitoxantrone—TOP2A—Azacitidine—Gemcitabine—hematologic cancer	8.68e-06	0.00784	CbGdCrCtD
Mitoxantrone—TOP2A—Azacitidine—Cytarabine—hematologic cancer	8.68e-06	0.00784	CbGdCrCtD
Mitoxantrone—TOP2A—Azacitidine—Cladribine—hematologic cancer	8.46e-06	0.00764	CbGdCrCtD
Mitoxantrone—Anxiety—Prednisone—hematologic cancer	5.44e-06	7.39e-05	CcSEcCtD
Mitoxantrone—Alopecia—Methotrexate—hematologic cancer	5.44e-06	7.39e-05	CcSEcCtD
Mitoxantrone—Vomiting—Gemcitabine—hematologic cancer	5.44e-06	7.38e-05	CcSEcCtD
Mitoxantrone—Bradycardia—Doxorubicin—hematologic cancer	5.43e-06	7.37e-05	CcSEcCtD
Mitoxantrone—Paraesthesia—Dexamethasone—hematologic cancer	5.4e-06	7.33e-05	CcSEcCtD
Mitoxantrone—Paraesthesia—Betamethasone—hematologic cancer	5.4e-06	7.33e-05	CcSEcCtD
Mitoxantrone—Discomfort—Prednisone—hematologic cancer	5.39e-06	7.32e-05	CcSEcCtD
Mitoxantrone—Rash—Gemcitabine—hematologic cancer	5.39e-06	7.32e-05	CcSEcCtD
Mitoxantrone—Dermatitis—Gemcitabine—hematologic cancer	5.39e-06	7.31e-05	CcSEcCtD
Mitoxantrone—Hypersensitivity—Etoposide—hematologic cancer	5.38e-06	7.31e-05	CcSEcCtD
Mitoxantrone—Erythema—Methotrexate—hematologic cancer	5.36e-06	7.28e-05	CcSEcCtD
Mitoxantrone—Haemoglobin—Doxorubicin—hematologic cancer	5.36e-06	7.28e-05	CcSEcCtD
Mitoxantrone—Headache—Gemcitabine—hematologic cancer	5.36e-06	7.27e-05	CcSEcCtD
Mitoxantrone—Nausea—Vincristine—hematologic cancer	5.35e-06	7.27e-05	CcSEcCtD
Mitoxantrone—Rhinitis—Doxorubicin—hematologic cancer	5.34e-06	7.26e-05	CcSEcCtD
Mitoxantrone—Hepatitis—Doxorubicin—hematologic cancer	5.33e-06	7.24e-05	CcSEcCtD
Mitoxantrone—Haemorrhage—Doxorubicin—hematologic cancer	5.33e-06	7.24e-05	CcSEcCtD
Mitoxantrone—Hypersensitivity—Prednisolone—hematologic cancer	5.31e-06	7.21e-05	CcSEcCtD
Mitoxantrone—Pharyngitis—Doxorubicin—hematologic cancer	5.29e-06	7.18e-05	CcSEcCtD
Mitoxantrone—Dyspepsia—Betamethasone—hematologic cancer	5.29e-06	7.18e-05	CcSEcCtD
Mitoxantrone—Dyspepsia—Dexamethasone—hematologic cancer	5.29e-06	7.18e-05	CcSEcCtD
Mitoxantrone—Urticaria—Triamcinolone—hematologic cancer	5.26e-06	7.14e-05	CcSEcCtD
Mitoxantrone—Dysgeusia—Methotrexate—hematologic cancer	5.25e-06	7.13e-05	CcSEcCtD
Mitoxantrone—Asthenia—Etoposide—hematologic cancer	5.24e-06	7.11e-05	CcSEcCtD
Mitoxantrone—Body temperature increased—Triamcinolone—hematologic cancer	5.23e-06	7.11e-05	CcSEcCtD
Mitoxantrone—Oedema—Prednisone—hematologic cancer	5.23e-06	7.11e-05	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Prednisone—hematologic cancer	5.23e-06	7.11e-05	CcSEcCtD
Mitoxantrone—Decreased appetite—Betamethasone—hematologic cancer	5.22e-06	7.09e-05	CcSEcCtD
Mitoxantrone—Decreased appetite—Dexamethasone—hematologic cancer	5.22e-06	7.09e-05	CcSEcCtD
Mitoxantrone—Nausea—Irinotecan—hematologic cancer	5.21e-06	7.08e-05	CcSEcCtD
Mitoxantrone—Infection—Prednisone—hematologic cancer	5.2e-06	7.06e-05	CcSEcCtD
Mitoxantrone—Back pain—Methotrexate—hematologic cancer	5.18e-06	7.04e-05	CcSEcCtD
Mitoxantrone—TOP2A—Methyltestosterone—Prednisone—hematologic cancer	5.18e-06	0.00468	CbGdCrCtD
Mitoxantrone—Fatigue—Dexamethasone—hematologic cancer	5.18e-06	7.04e-05	CcSEcCtD
Mitoxantrone—Fatigue—Betamethasone—hematologic cancer	5.18e-06	7.04e-05	CcSEcCtD
Mitoxantrone—Chills—Epirubicin—hematologic cancer	5.17e-06	7.02e-05	CcSEcCtD
Mitoxantrone—Shock—Prednisone—hematologic cancer	5.15e-06	6.99e-05	CcSEcCtD
Mitoxantrone—Arrhythmia—Epirubicin—hematologic cancer	5.15e-06	6.99e-05	CcSEcCtD
Mitoxantrone—Pain—Betamethasone—hematologic cancer	5.14e-06	6.98e-05	CcSEcCtD
Mitoxantrone—Pain—Dexamethasone—hematologic cancer	5.14e-06	6.98e-05	CcSEcCtD
Mitoxantrone—Tachycardia—Prednisone—hematologic cancer	5.11e-06	6.94e-05	CcSEcCtD
Mitoxantrone—Alopecia—Epirubicin—hematologic cancer	5.09e-06	6.91e-05	CcSEcCtD
Mitoxantrone—Skin disorder—Prednisone—hematologic cancer	5.08e-06	6.9e-05	CcSEcCtD
Mitoxantrone—Nausea—Gemcitabine—hematologic cancer	5.08e-06	6.9e-05	CcSEcCtD
Mitoxantrone—Vomiting—Cisplatin—hematologic cancer	5.07e-06	6.88e-05	CcSEcCtD
Mitoxantrone—TOP2A—Methyltestosterone—Prednisolone—hematologic cancer	5.06e-06	0.00457	CbGdCrCtD
Mitoxantrone—Hyperhidrosis—Prednisone—hematologic cancer	5.06e-06	6.87e-05	CcSEcCtD
Mitoxantrone—Vision blurred—Methotrexate—hematologic cancer	5.05e-06	6.86e-05	CcSEcCtD
Mitoxantrone—Rash—Cisplatin—hematologic cancer	5.02e-06	6.82e-05	CcSEcCtD
Mitoxantrone—Dermatitis—Cisplatin—hematologic cancer	5.02e-06	6.82e-05	CcSEcCtD
Mitoxantrone—Erythema—Epirubicin—hematologic cancer	5.01e-06	6.81e-05	CcSEcCtD
Mitoxantrone—Diarrhoea—Etoposide—hematologic cancer	5e-06	6.78e-05	CcSEcCtD
Mitoxantrone—Anorexia—Prednisone—hematologic cancer	4.99e-06	6.77e-05	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Methotrexate—hematologic cancer	4.97e-06	6.75e-05	CcSEcCtD
Mitoxantrone—Anaemia—Methotrexate—hematologic cancer	4.95e-06	6.73e-05	CcSEcCtD
Mitoxantrone—Feeling abnormal—Betamethasone—hematologic cancer	4.95e-06	6.72e-05	CcSEcCtD
Mitoxantrone—Feeling abnormal—Dexamethasone—hematologic cancer	4.95e-06	6.72e-05	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Betamethasone—hematologic cancer	4.91e-06	6.67e-05	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.91e-06	6.67e-05	CcSEcCtD
Mitoxantrone—Dysgeusia—Epirubicin—hematologic cancer	4.91e-06	6.67e-05	CcSEcCtD
Mitoxantrone—Hypersensitivity—Triamcinolone—hematologic cancer	4.88e-06	6.63e-05	CcSEcCtD
Mitoxantrone—Back pain—Epirubicin—hematologic cancer	4.85e-06	6.59e-05	CcSEcCtD
Mitoxantrone—Malaise—Methotrexate—hematologic cancer	4.83e-06	6.56e-05	CcSEcCtD
Mitoxantrone—Leukopenia—Methotrexate—hematologic cancer	4.8e-06	6.51e-05	CcSEcCtD
Mitoxantrone—Chills—Doxorubicin—hematologic cancer	4.78e-06	6.5e-05	CcSEcCtD
Mitoxantrone—Urticaria—Dexamethasone—hematologic cancer	4.77e-06	6.48e-05	CcSEcCtD
Mitoxantrone—Urticaria—Betamethasone—hematologic cancer	4.77e-06	6.48e-05	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.77e-06	6.47e-05	CcSEcCtD
Mitoxantrone—Arrhythmia—Doxorubicin—hematologic cancer	4.76e-06	6.47e-05	CcSEcCtD
Mitoxantrone—Asthenia—Triamcinolone—hematologic cancer	4.75e-06	6.45e-05	CcSEcCtD
Mitoxantrone—Abdominal pain—Betamethasone—hematologic cancer	4.75e-06	6.45e-05	CcSEcCtD
Mitoxantrone—Body temperature increased—Betamethasone—hematologic cancer	4.75e-06	6.45e-05	CcSEcCtD
Mitoxantrone—Abdominal pain—Dexamethasone—hematologic cancer	4.75e-06	6.45e-05	CcSEcCtD
Mitoxantrone—Body temperature increased—Dexamethasone—hematologic cancer	4.75e-06	6.45e-05	CcSEcCtD
Mitoxantrone—Nausea—Cisplatin—hematologic cancer	4.73e-06	6.43e-05	CcSEcCtD
Mitoxantrone—Vision blurred—Epirubicin—hematologic cancer	4.73e-06	6.42e-05	CcSEcCtD
Mitoxantrone—Alopecia—Doxorubicin—hematologic cancer	4.71e-06	6.4e-05	CcSEcCtD
Mitoxantrone—Paraesthesia—Prednisone—hematologic cancer	4.7e-06	6.38e-05	CcSEcCtD
Mitoxantrone—Cough—Methotrexate—hematologic cancer	4.68e-06	6.35e-05	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Epirubicin—hematologic cancer	4.65e-06	6.32e-05	CcSEcCtD
Mitoxantrone—Convulsion—Methotrexate—hematologic cancer	4.64e-06	6.31e-05	CcSEcCtD
Mitoxantrone—Vomiting—Etoposide—hematologic cancer	4.64e-06	6.3e-05	CcSEcCtD
Mitoxantrone—Erythema—Doxorubicin—hematologic cancer	4.64e-06	6.3e-05	CcSEcCtD
Mitoxantrone—Anaemia—Epirubicin—hematologic cancer	4.63e-06	6.29e-05	CcSEcCtD
Mitoxantrone—Dyspepsia—Prednisone—hematologic cancer	4.61e-06	6.26e-05	CcSEcCtD
Mitoxantrone—Rash—Etoposide—hematologic cancer	4.6e-06	6.25e-05	CcSEcCtD
Mitoxantrone—Dermatitis—Etoposide—hematologic cancer	4.6e-06	6.25e-05	CcSEcCtD
Mitoxantrone—Headache—Etoposide—hematologic cancer	4.57e-06	6.21e-05	CcSEcCtD
Mitoxantrone—Arthralgia—Methotrexate—hematologic cancer	4.56e-06	6.2e-05	CcSEcCtD
Mitoxantrone—Chest pain—Methotrexate—hematologic cancer	4.56e-06	6.2e-05	CcSEcCtD
Mitoxantrone—Myalgia—Methotrexate—hematologic cancer	4.56e-06	6.2e-05	CcSEcCtD
Mitoxantrone—Decreased appetite—Prednisone—hematologic cancer	4.55e-06	6.18e-05	CcSEcCtD
Mitoxantrone—Dysgeusia—Doxorubicin—hematologic cancer	4.54e-06	6.17e-05	CcSEcCtD
Mitoxantrone—Rash—Prednisolone—hematologic cancer	4.54e-06	6.17e-05	CcSEcCtD
Mitoxantrone—Dermatitis—Prednisolone—hematologic cancer	4.54e-06	6.16e-05	CcSEcCtD
Mitoxantrone—Malaise—Epirubicin—hematologic cancer	4.52e-06	6.14e-05	CcSEcCtD
Mitoxantrone—Fatigue—Prednisone—hematologic cancer	4.51e-06	6.13e-05	CcSEcCtD
Mitoxantrone—Headache—Prednisolone—hematologic cancer	4.51e-06	6.13e-05	CcSEcCtD
Mitoxantrone—Discomfort—Methotrexate—hematologic cancer	4.51e-06	6.12e-05	CcSEcCtD
Mitoxantrone—Leukopenia—Epirubicin—hematologic cancer	4.49e-06	6.1e-05	CcSEcCtD
Mitoxantrone—Back pain—Doxorubicin—hematologic cancer	4.49e-06	6.1e-05	CcSEcCtD
Mitoxantrone—Constipation—Prednisone—hematologic cancer	4.47e-06	6.08e-05	CcSEcCtD
Mitoxantrone—Confusional state—Methotrexate—hematologic cancer	4.41e-06	5.99e-05	CcSEcCtD
Mitoxantrone—Cough—Epirubicin—hematologic cancer	4.38e-06	5.94e-05	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Methotrexate—hematologic cancer	4.37e-06	5.94e-05	CcSEcCtD
Mitoxantrone—Vision blurred—Doxorubicin—hematologic cancer	4.37e-06	5.94e-05	CcSEcCtD
Mitoxantrone—Convulsion—Epirubicin—hematologic cancer	4.34e-06	5.9e-05	CcSEcCtD
Mitoxantrone—Infection—Methotrexate—hematologic cancer	4.34e-06	5.9e-05	CcSEcCtD
Mitoxantrone—Nausea—Etoposide—hematologic cancer	4.34e-06	5.89e-05	CcSEcCtD
Mitoxantrone—Hypertension—Epirubicin—hematologic cancer	4.33e-06	5.88e-05	CcSEcCtD
Mitoxantrone—Feeling abnormal—Prednisone—hematologic cancer	4.31e-06	5.86e-05	CcSEcCtD
Mitoxantrone—Asthenia—Betamethasone—hematologic cancer	4.31e-06	5.85e-05	CcSEcCtD
Mitoxantrone—Asthenia—Dexamethasone—hematologic cancer	4.31e-06	5.85e-05	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Doxorubicin—hematologic cancer	4.3e-06	5.85e-05	CcSEcCtD
Mitoxantrone—Anaemia—Doxorubicin—hematologic cancer	4.29e-06	5.82e-05	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Methotrexate—hematologic cancer	4.28e-06	5.82e-05	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Prednisone—hematologic cancer	4.28e-06	5.81e-05	CcSEcCtD
Mitoxantrone—Nausea—Prednisolone—hematologic cancer	4.28e-06	5.81e-05	CcSEcCtD
Mitoxantrone—Chest pain—Epirubicin—hematologic cancer	4.27e-06	5.8e-05	CcSEcCtD
Mitoxantrone—Arthralgia—Epirubicin—hematologic cancer	4.27e-06	5.8e-05	CcSEcCtD
Mitoxantrone—Myalgia—Epirubicin—hematologic cancer	4.27e-06	5.8e-05	CcSEcCtD
Mitoxantrone—Anxiety—Epirubicin—hematologic cancer	4.25e-06	5.78e-05	CcSEcCtD
Mitoxantrone—Skin disorder—Methotrexate—hematologic cancer	4.25e-06	5.77e-05	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Methotrexate—hematologic cancer	4.23e-06	5.74e-05	CcSEcCtD
Mitoxantrone—Discomfort—Epirubicin—hematologic cancer	4.22e-06	5.73e-05	CcSEcCtD
Mitoxantrone—Vomiting—Triamcinolone—hematologic cancer	4.21e-06	5.72e-05	CcSEcCtD
Mitoxantrone—Malaise—Doxorubicin—hematologic cancer	4.18e-06	5.68e-05	CcSEcCtD
Mitoxantrone—Rash—Triamcinolone—hematologic cancer	4.18e-06	5.67e-05	CcSEcCtD
Mitoxantrone—Dermatitis—Triamcinolone—hematologic cancer	4.17e-06	5.67e-05	CcSEcCtD
Mitoxantrone—Anorexia—Methotrexate—hematologic cancer	4.17e-06	5.66e-05	CcSEcCtD
Mitoxantrone—Urticaria—Prednisone—hematologic cancer	4.16e-06	5.65e-05	CcSEcCtD
Mitoxantrone—Leukopenia—Doxorubicin—hematologic cancer	4.15e-06	5.64e-05	CcSEcCtD
Mitoxantrone—Headache—Triamcinolone—hematologic cancer	4.15e-06	5.63e-05	CcSEcCtD
Mitoxantrone—Abdominal pain—Prednisone—hematologic cancer	4.14e-06	5.62e-05	CcSEcCtD
Mitoxantrone—Body temperature increased—Prednisone—hematologic cancer	4.14e-06	5.62e-05	CcSEcCtD
Mitoxantrone—Confusional state—Epirubicin—hematologic cancer	4.13e-06	5.6e-05	CcSEcCtD
Mitoxantrone—Diarrhoea—Dexamethasone—hematologic cancer	4.11e-06	5.58e-05	CcSEcCtD
Mitoxantrone—Diarrhoea—Betamethasone—hematologic cancer	4.11e-06	5.58e-05	CcSEcCtD
Mitoxantrone—Oedema—Epirubicin—hematologic cancer	4.09e-06	5.56e-05	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Epirubicin—hematologic cancer	4.09e-06	5.56e-05	CcSEcCtD
Mitoxantrone—Hypotension—Methotrexate—hematologic cancer	4.09e-06	5.55e-05	CcSEcCtD
Mitoxantrone—Infection—Epirubicin—hematologic cancer	4.07e-06	5.52e-05	CcSEcCtD
Mitoxantrone—Cough—Doxorubicin—hematologic cancer	4.05e-06	5.5e-05	CcSEcCtD
Mitoxantrone—Shock—Epirubicin—hematologic cancer	4.03e-06	5.47e-05	CcSEcCtD
Mitoxantrone—Convulsion—Doxorubicin—hematologic cancer	4.02e-06	5.46e-05	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Epirubicin—hematologic cancer	4.01e-06	5.44e-05	CcSEcCtD
Mitoxantrone—Hypertension—Doxorubicin—hematologic cancer	4.01e-06	5.44e-05	CcSEcCtD
Mitoxantrone—Tachycardia—Epirubicin—hematologic cancer	3.99e-06	5.42e-05	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.98e-06	5.41e-05	CcSEcCtD
Mitoxantrone—Skin disorder—Epirubicin—hematologic cancer	3.98e-06	5.4e-05	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Epirubicin—hematologic cancer	3.96e-06	5.37e-05	CcSEcCtD
Mitoxantrone—Myalgia—Doxorubicin—hematologic cancer	3.95e-06	5.36e-05	CcSEcCtD
Mitoxantrone—Chest pain—Doxorubicin—hematologic cancer	3.95e-06	5.36e-05	CcSEcCtD
Mitoxantrone—Arthralgia—Doxorubicin—hematologic cancer	3.95e-06	5.36e-05	CcSEcCtD
Mitoxantrone—Anxiety—Doxorubicin—hematologic cancer	3.94e-06	5.35e-05	CcSEcCtD
Mitoxantrone—Nausea—Triamcinolone—hematologic cancer	3.93e-06	5.34e-05	CcSEcCtD
Mitoxantrone—Paraesthesia—Methotrexate—hematologic cancer	3.93e-06	5.33e-05	CcSEcCtD
Mitoxantrone—Discomfort—Doxorubicin—hematologic cancer	3.9e-06	5.3e-05	CcSEcCtD
Mitoxantrone—Anorexia—Epirubicin—hematologic cancer	3.9e-06	5.3e-05	CcSEcCtD
Mitoxantrone—Dyspnoea—Methotrexate—hematologic cancer	3.9e-06	5.3e-05	CcSEcCtD
Mitoxantrone—Somnolence—Methotrexate—hematologic cancer	3.89e-06	5.28e-05	CcSEcCtD
Mitoxantrone—Hypersensitivity—Prednisone—hematologic cancer	3.86e-06	5.24e-05	CcSEcCtD
Mitoxantrone—Dyspepsia—Methotrexate—hematologic cancer	3.85e-06	5.23e-05	CcSEcCtD
Mitoxantrone—Hypotension—Epirubicin—hematologic cancer	3.82e-06	5.19e-05	CcSEcCtD
Mitoxantrone—Vomiting—Betamethasone—hematologic cancer	3.82e-06	5.19e-05	CcSEcCtD
Mitoxantrone—Vomiting—Dexamethasone—hematologic cancer	3.82e-06	5.19e-05	CcSEcCtD
Mitoxantrone—Confusional state—Doxorubicin—hematologic cancer	3.82e-06	5.19e-05	CcSEcCtD
Mitoxantrone—Decreased appetite—Methotrexate—hematologic cancer	3.8e-06	5.16e-05	CcSEcCtD
Mitoxantrone—Rash—Dexamethasone—hematologic cancer	3.79e-06	5.15e-05	CcSEcCtD
Mitoxantrone—Rash—Betamethasone—hematologic cancer	3.79e-06	5.15e-05	CcSEcCtD
Mitoxantrone—Oedema—Doxorubicin—hematologic cancer	3.79e-06	5.14e-05	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Doxorubicin—hematologic cancer	3.79e-06	5.14e-05	CcSEcCtD
Mitoxantrone—Dermatitis—Dexamethasone—hematologic cancer	3.78e-06	5.14e-05	CcSEcCtD
Mitoxantrone—Dermatitis—Betamethasone—hematologic cancer	3.78e-06	5.14e-05	CcSEcCtD
Mitoxantrone—Fatigue—Methotrexate—hematologic cancer	3.77e-06	5.12e-05	CcSEcCtD
Mitoxantrone—Headache—Dexamethasone—hematologic cancer	3.76e-06	5.11e-05	CcSEcCtD
Mitoxantrone—Headache—Betamethasone—hematologic cancer	3.76e-06	5.11e-05	CcSEcCtD
Mitoxantrone—Infection—Doxorubicin—hematologic cancer	3.76e-06	5.11e-05	CcSEcCtD
Mitoxantrone—Asthenia—Prednisone—hematologic cancer	3.75e-06	5.1e-05	CcSEcCtD
Mitoxantrone—Pain—Methotrexate—hematologic cancer	3.74e-06	5.08e-05	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.73e-06	5.06e-05	CcSEcCtD
Mitoxantrone—Shock—Doxorubicin—hematologic cancer	3.73e-06	5.06e-05	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Doxorubicin—hematologic cancer	3.71e-06	5.04e-05	CcSEcCtD
Mitoxantrone—Tachycardia—Doxorubicin—hematologic cancer	3.7e-06	5.02e-05	CcSEcCtD
Mitoxantrone—Skin disorder—Doxorubicin—hematologic cancer	3.68e-06	5e-05	CcSEcCtD
Mitoxantrone—Paraesthesia—Epirubicin—hematologic cancer	3.67e-06	4.99e-05	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Doxorubicin—hematologic cancer	3.66e-06	4.97e-05	CcSEcCtD
Mitoxantrone—Dyspnoea—Epirubicin—hematologic cancer	3.65e-06	4.96e-05	CcSEcCtD
Mitoxantrone—Somnolence—Epirubicin—hematologic cancer	3.64e-06	4.94e-05	CcSEcCtD
Mitoxantrone—Anorexia—Doxorubicin—hematologic cancer	3.61e-06	4.9e-05	CcSEcCtD
Mitoxantrone—Feeling abnormal—Methotrexate—hematologic cancer	3.6e-06	4.89e-05	CcSEcCtD
Mitoxantrone—Dyspepsia—Epirubicin—hematologic cancer	3.6e-06	4.89e-05	CcSEcCtD
Mitoxantrone—Diarrhoea—Prednisone—hematologic cancer	3.58e-06	4.86e-05	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Methotrexate—hematologic cancer	3.58e-06	4.86e-05	CcSEcCtD
Mitoxantrone—Nausea—Dexamethasone—hematologic cancer	3.57e-06	4.85e-05	CcSEcCtD
Mitoxantrone—Nausea—Betamethasone—hematologic cancer	3.57e-06	4.85e-05	CcSEcCtD
Mitoxantrone—Decreased appetite—Epirubicin—hematologic cancer	3.56e-06	4.83e-05	CcSEcCtD
Mitoxantrone—Hypotension—Doxorubicin—hematologic cancer	3.54e-06	4.81e-05	CcSEcCtD
Mitoxantrone—Fatigue—Epirubicin—hematologic cancer	3.53e-06	4.79e-05	CcSEcCtD
Mitoxantrone—Pain—Epirubicin—hematologic cancer	3.5e-06	4.75e-05	CcSEcCtD
Mitoxantrone—Constipation—Epirubicin—hematologic cancer	3.5e-06	4.75e-05	CcSEcCtD
Mitoxantrone—Urticaria—Methotrexate—hematologic cancer	3.47e-06	4.72e-05	CcSEcCtD
Mitoxantrone—Abdominal pain—Methotrexate—hematologic cancer	3.46e-06	4.7e-05	CcSEcCtD
Mitoxantrone—Body temperature increased—Methotrexate—hematologic cancer	3.46e-06	4.7e-05	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.45e-06	4.69e-05	CcSEcCtD
Mitoxantrone—Paraesthesia—Doxorubicin—hematologic cancer	3.4e-06	4.62e-05	CcSEcCtD
Mitoxantrone—Dyspnoea—Doxorubicin—hematologic cancer	3.38e-06	4.58e-05	CcSEcCtD
Mitoxantrone—Feeling abnormal—Epirubicin—hematologic cancer	3.37e-06	4.58e-05	CcSEcCtD
Mitoxantrone—Somnolence—Doxorubicin—hematologic cancer	3.37e-06	4.57e-05	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Epirubicin—hematologic cancer	3.35e-06	4.54e-05	CcSEcCtD
Mitoxantrone—Dyspepsia—Doxorubicin—hematologic cancer	3.33e-06	4.53e-05	CcSEcCtD
Mitoxantrone—Vomiting—Prednisone—hematologic cancer	3.33e-06	4.52e-05	CcSEcCtD
Mitoxantrone—Rash—Prednisone—hematologic cancer	3.3e-06	4.48e-05	CcSEcCtD
Mitoxantrone—Dermatitis—Prednisone—hematologic cancer	3.3e-06	4.48e-05	CcSEcCtD
Mitoxantrone—Decreased appetite—Doxorubicin—hematologic cancer	3.29e-06	4.47e-05	CcSEcCtD
Mitoxantrone—Headache—Prednisone—hematologic cancer	3.28e-06	4.45e-05	CcSEcCtD
Mitoxantrone—Fatigue—Doxorubicin—hematologic cancer	3.26e-06	4.43e-05	CcSEcCtD
Mitoxantrone—Urticaria—Epirubicin—hematologic cancer	3.25e-06	4.42e-05	CcSEcCtD
Mitoxantrone—Constipation—Doxorubicin—hematologic cancer	3.24e-06	4.4e-05	CcSEcCtD
Mitoxantrone—Pain—Doxorubicin—hematologic cancer	3.24e-06	4.4e-05	CcSEcCtD
Mitoxantrone—Abdominal pain—Epirubicin—hematologic cancer	3.24e-06	4.39e-05	CcSEcCtD
Mitoxantrone—Body temperature increased—Epirubicin—hematologic cancer	3.24e-06	4.39e-05	CcSEcCtD
Mitoxantrone—Hypersensitivity—Methotrexate—hematologic cancer	3.22e-06	4.38e-05	CcSEcCtD
Mitoxantrone—Asthenia—Methotrexate—hematologic cancer	3.14e-06	4.26e-05	CcSEcCtD
Mitoxantrone—Feeling abnormal—Doxorubicin—hematologic cancer	3.12e-06	4.24e-05	CcSEcCtD
Mitoxantrone—Nausea—Prednisone—hematologic cancer	3.11e-06	4.22e-05	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.1e-06	4.21e-05	CcSEcCtD
Mitoxantrone—Hypersensitivity—Epirubicin—hematologic cancer	3.02e-06	4.09e-05	CcSEcCtD
Mitoxantrone—Urticaria—Doxorubicin—hematologic cancer	3.01e-06	4.09e-05	CcSEcCtD
Mitoxantrone—Body temperature increased—Doxorubicin—hematologic cancer	2.99e-06	4.07e-05	CcSEcCtD
Mitoxantrone—Abdominal pain—Doxorubicin—hematologic cancer	2.99e-06	4.07e-05	CcSEcCtD
Mitoxantrone—Diarrhoea—Methotrexate—hematologic cancer	2.99e-06	4.06e-05	CcSEcCtD
Mitoxantrone—Asthenia—Epirubicin—hematologic cancer	2.94e-06	3.99e-05	CcSEcCtD
Mitoxantrone—Diarrhoea—Epirubicin—hematologic cancer	2.8e-06	3.8e-05	CcSEcCtD
Mitoxantrone—Hypersensitivity—Doxorubicin—hematologic cancer	2.79e-06	3.79e-05	CcSEcCtD
Mitoxantrone—Vomiting—Methotrexate—hematologic cancer	2.78e-06	3.78e-05	CcSEcCtD
Mitoxantrone—Rash—Methotrexate—hematologic cancer	2.76e-06	3.74e-05	CcSEcCtD
Mitoxantrone—Dermatitis—Methotrexate—hematologic cancer	2.75e-06	3.74e-05	CcSEcCtD
Mitoxantrone—Headache—Methotrexate—hematologic cancer	2.74e-06	3.72e-05	CcSEcCtD
Mitoxantrone—Asthenia—Doxorubicin—hematologic cancer	2.72e-06	3.69e-05	CcSEcCtD
Mitoxantrone—Vomiting—Epirubicin—hematologic cancer	2.6e-06	3.53e-05	CcSEcCtD
Mitoxantrone—Nausea—Methotrexate—hematologic cancer	2.6e-06	3.53e-05	CcSEcCtD
Mitoxantrone—Diarrhoea—Doxorubicin—hematologic cancer	2.59e-06	3.52e-05	CcSEcCtD
Mitoxantrone—Rash—Epirubicin—hematologic cancer	2.58e-06	3.5e-05	CcSEcCtD
Mitoxantrone—Dermatitis—Epirubicin—hematologic cancer	2.58e-06	3.5e-05	CcSEcCtD
Mitoxantrone—Headache—Epirubicin—hematologic cancer	2.56e-06	3.48e-05	CcSEcCtD
Mitoxantrone—Nausea—Epirubicin—hematologic cancer	2.43e-06	3.3e-05	CcSEcCtD
Mitoxantrone—Vomiting—Doxorubicin—hematologic cancer	2.41e-06	3.27e-05	CcSEcCtD
Mitoxantrone—Rash—Doxorubicin—hematologic cancer	2.39e-06	3.24e-05	CcSEcCtD
Mitoxantrone—Dermatitis—Doxorubicin—hematologic cancer	2.39e-06	3.24e-05	CcSEcCtD
Mitoxantrone—Headache—Doxorubicin—hematologic cancer	2.37e-06	3.22e-05	CcSEcCtD
Mitoxantrone—Nausea—Doxorubicin—hematologic cancer	2.25e-06	3.05e-05	CcSEcCtD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.47e-06	3.52e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AGRN—hematologic cancer	1.46e-06	3.51e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYCS—hematologic cancer	1.46e-06	3.51e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NCOR1—hematologic cancer	1.46e-06	3.51e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—HSP90AA1—hematologic cancer	1.45e-06	3.48e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGF1—hematologic cancer	1.45e-06	3.47e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CRABP1—hematologic cancer	1.43e-06	3.43e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC22A1—hematologic cancer	1.43e-06	3.43e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.43e-06	3.42e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FOXO1—hematologic cancer	1.43e-06	3.42e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PDGFRB—hematologic cancer	1.42e-06	3.41e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NQO1—hematologic cancer	1.41e-06	3.37e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CD44—hematologic cancer	1.41e-06	3.37e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PDGFRA—hematologic cancer	1.4e-06	3.36e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.4e-06	3.35e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ASNS—hematologic cancer	1.4e-06	3.35e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—DCK—hematologic cancer	1.4e-06	3.35e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALOX5—hematologic cancer	1.4e-06	3.35e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PRKCG—hematologic cancer	1.4e-06	3.35e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—JAK1—hematologic cancer	1.4e-06	3.35e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.39e-06	3.33e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HMMR—hematologic cancer	1.39e-06	3.33e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—IDH2—hematologic cancer	1.39e-06	3.33e-05	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TP53—hematologic cancer	1.38e-06	3.31e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NUP98—hematologic cancer	1.35e-06	3.24e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.35e-06	3.24e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTP1—hematologic cancer	1.33e-06	3.19e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYCS—hematologic cancer	1.33e-06	3.19e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—KRAS—hematologic cancer	1.33e-06	3.18e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HDC—hematologic cancer	1.33e-06	3.18e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—HSP90AA1—hematologic cancer	1.32e-06	3.17e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.32e-06	3.15e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ADCY7—hematologic cancer	1.31e-06	3.15e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NCOA3—hematologic cancer	1.31e-06	3.15e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.31e-06	3.13e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ARNTL—hematologic cancer	1.31e-06	3.13e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NUP214—hematologic cancer	1.3e-06	3.12e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTHFR—hematologic cancer	1.29e-06	3.1e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.29e-06	3.09e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTP1—hematologic cancer	1.29e-06	3.09e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HLA-A—hematologic cancer	1.29e-06	3.09e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TERT—hematologic cancer	1.29e-06	3.09e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.28e-06	3.07e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ABCG2—hematologic cancer	1.28e-06	3.06e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MTR—hematologic cancer	1.28e-06	3.06e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.28e-06	3.06e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ACP5—hematologic cancer	1.27e-06	3.04e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CA9—hematologic cancer	1.27e-06	3.04e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ABCB1—hematologic cancer	1.26e-06	3.02e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PDGFB—hematologic cancer	1.26e-06	3.02e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NCOR2—hematologic cancer	1.25e-06	3e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ENO2—hematologic cancer	1.25e-06	3e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.25e-06	2.99e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TSC2—hematologic cancer	1.23e-06	2.95e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—NCOR1—hematologic cancer	1.23e-06	2.94e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GSTM1—hematologic cancer	1.23e-06	2.94e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—PIK3CA—hematologic cancer	1.22e-06	2.93e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ABCB1—hematologic cancer	1.22e-06	2.92e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTT1—hematologic cancer	1.22e-06	2.91e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CDA—hematologic cancer	1.21e-06	2.91e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—IDH1—hematologic cancer	1.19e-06	2.86e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.19e-06	2.86e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SDC1—hematologic cancer	1.19e-06	2.85e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—NCOR1—hematologic cancer	1.19e-06	2.84e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GSTM1—hematologic cancer	1.19e-06	2.84e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.18e-06	2.84e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGFR3—hematologic cancer	1.18e-06	2.83e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ABCC3—hematologic cancer	1.18e-06	2.83e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TXN—hematologic cancer	1.18e-06	2.83e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTO1—hematologic cancer	1.18e-06	2.83e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTP1—hematologic cancer	1.17e-06	2.81e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PC—hematologic cancer	1.17e-06	2.8e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SPHK1—hematologic cancer	1.16e-06	2.77e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HRAS—hematologic cancer	1.13e-06	2.71e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GBA—hematologic cancer	1.13e-06	2.7e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.13e-06	2.7e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—BAD—hematologic cancer	1.12e-06	2.69e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOTCH1—hematologic cancer	1.11e-06	2.66e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ABCB1—hematologic cancer	1.11e-06	2.66e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—UGT1A1—hematologic cancer	1.11e-06	2.66e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD80—hematologic cancer	1.09e-06	2.61e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.09e-06	2.6e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KIT—hematologic cancer	1.09e-06	2.6e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MTHFR—hematologic cancer	1.08e-06	2.59e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6—hematologic cancer	1.08e-06	2.59e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CRABP1—hematologic cancer	1.08e-06	2.59e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC22A1—hematologic cancer	1.08e-06	2.59e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NCOR1—hematologic cancer	1.08e-06	2.58e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTM1—hematologic cancer	1.08e-06	2.58e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTPN11—hematologic cancer	1.07e-06	2.56e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALOX5—hematologic cancer	1.05e-06	2.52e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.05e-06	2.52e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MTHFR—hematologic cancer	1.05e-06	2.51e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CREB1—hematologic cancer	1.03e-06	2.48e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTAP—hematologic cancer	1.03e-06	2.47e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—BRAF—hematologic cancer	1.02e-06	2.45e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NUP98—hematologic cancer	1.02e-06	2.44e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CD44—hematologic cancer	1.01e-06	2.42e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NQO1—hematologic cancer	1.01e-06	2.42e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6R—hematologic cancer	1.01e-06	2.42e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CREBBP—hematologic cancer	1.01e-06	2.41e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—AKT1—hematologic cancer	9.98e-07	2.39e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ADCY7—hematologic cancer	9.89e-07	2.37e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NCOA3—hematologic cancer	9.89e-07	2.37e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NUP214—hematologic cancer	9.82e-07	2.35e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTR—hematologic cancer	9.62e-07	2.31e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ABCG2—hematologic cancer	9.62e-07	2.31e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAP2K1—hematologic cancer	9.62e-07	2.3e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYCS—hematologic cancer	9.56e-07	2.29e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CD—hematologic cancer	9.55e-07	2.29e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.54e-07	2.29e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MTHFR—hematologic cancer	9.53e-07	2.28e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	9.5e-07	2.28e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ENO2—hematologic cancer	9.44e-07	2.26e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.23e-07	2.21e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—FHL2—hematologic cancer	9.2e-07	2.2e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTT1—hematologic cancer	9.15e-07	2.19e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGF2—hematologic cancer	9.15e-07	2.19e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CG—hematologic cancer	9.1e-07	2.18e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AGRN—hematologic cancer	9.02e-07	2.16e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3R1—hematologic cancer	9.02e-07	2.16e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SDC1—hematologic cancer	8.95e-07	2.14e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	8.88e-07	2.13e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CG—hematologic cancer	8.8e-07	2.11e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—JAK2—hematologic cancer	8.77e-07	2.1e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.57e-07	2.05e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MDM2—hematologic cancer	8.56e-07	2.05e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—IDH2—hematologic cancer	8.55e-07	2.05e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HMMR—hematologic cancer	8.55e-07	2.05e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CREBBP—hematologic cancer	8.44e-07	2.02e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTP1—hematologic cancer	8.43e-07	2.02e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CB—hematologic cancer	8.33e-07	1.99e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTOR—hematologic cancer	8.33e-07	1.99e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD4—hematologic cancer	8.31e-07	1.99e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CREBBP—hematologic cancer	8.16e-07	1.95e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ARNTL—hematologic cancer	8.04e-07	1.93e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	8.02e-07	1.92e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CG—hematologic cancer	8.01e-07	1.92e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CD—hematologic cancer	8e-07	1.92e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ABCB1—hematologic cancer	7.98e-07	1.91e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ALB—hematologic cancer	7.9e-07	1.89e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ACP5—hematologic cancer	7.82e-07	1.87e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CA9—hematologic cancer	7.82e-07	1.87e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN1B—hematologic cancer	7.81e-07	1.87e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTM1—hematologic cancer	7.74e-07	1.85e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NCOR1—hematologic cancer	7.74e-07	1.85e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CD—hematologic cancer	7.74e-07	1.85e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NCOR2—hematologic cancer	7.72e-07	1.85e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ALB—hematologic cancer	7.64e-07	1.83e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NQO1—hematologic cancer	7.61e-07	1.82e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CD44—hematologic cancer	7.61e-07	1.82e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3R1—hematologic cancer	7.55e-07	1.81e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CREBBP—hematologic cancer	7.42e-07	1.78e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—IDH1—hematologic cancer	7.36e-07	1.76e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3R1—hematologic cancer	7.31e-07	1.75e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTO1—hematologic cancer	7.27e-07	1.74e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCC3—hematologic cancer	7.27e-07	1.74e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TXN—hematologic cancer	7.27e-07	1.74e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN1A—hematologic cancer	7.21e-07	1.73e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYCS—hematologic cancer	7.2e-07	1.72e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTEN—hematologic cancer	7.19e-07	1.72e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HSP90AA1—hematologic cancer	7.15e-07	1.71e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SPHK1—hematologic cancer	7.12e-07	1.7e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CD—hematologic cancer	7.04e-07	1.69e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CB—hematologic cancer	6.97e-07	1.67e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ALB—hematologic cancer	6.95e-07	1.66e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EP300—hematologic cancer	6.86e-07	1.64e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MTHFR—hematologic cancer	6.84e-07	1.64e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	6.84e-07	1.64e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CB—hematologic cancer	6.74e-07	1.62e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SRC—hematologic cancer	6.67e-07	1.6e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CRABP1—hematologic cancer	6.65e-07	1.59e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	6.65e-07	1.59e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3R1—hematologic cancer	6.65e-07	1.59e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALOX5—hematologic cancer	6.48e-07	1.55e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—STAT3—hematologic cancer	6.43e-07	1.54e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NRAS—hematologic cancer	6.42e-07	1.54e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTP1—hematologic cancer	6.34e-07	1.52e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NUP98—hematologic cancer	6.28e-07	1.5e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAPK3—hematologic cancer	6.15e-07	1.47e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CB—hematologic cancer	6.14e-07	1.47e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.1e-07	1.46e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.1e-07	1.46e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NUP214—hematologic cancer	6.05e-07	1.45e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTEN—hematologic cancer	6.03e-07	1.44e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MYC—hematologic cancer	5.98e-07	1.43e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TGFB1—hematologic cancer	5.96e-07	1.43e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.93e-07	1.42e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTR—hematologic cancer	5.93e-07	1.42e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NCOR1—hematologic cancer	5.83e-07	1.4e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTM1—hematologic cancer	5.83e-07	1.4e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTEN—hematologic cancer	5.83e-07	1.4e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ENO2—hematologic cancer	5.81e-07	1.39e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CG—hematologic cancer	5.75e-07	1.38e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—EP300—hematologic cancer	5.75e-07	1.38e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.64e-07	1.35e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—EP300—hematologic cancer	5.56e-07	1.33e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KRAS—hematologic cancer	5.52e-07	1.32e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SDC1—hematologic cancer	5.51e-07	1.32e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CREBBP—hematologic cancer	5.33e-07	1.28e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTEN—hematologic cancer	5.3e-07	1.27e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTHFR—hematologic cancer	5.15e-07	1.23e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CA—hematologic cancer	5.08e-07	1.22e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—EP300—hematologic cancer	5.06e-07	1.21e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CD—hematologic cancer	5.05e-07	1.21e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALB—hematologic cancer	4.99e-07	1.2e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3R1—hematologic cancer	4.77e-07	1.14e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HRAS—hematologic cancer	4.7e-07	1.12e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CD44—hematologic cancer	4.69e-07	1.12e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NQO1—hematologic cancer	4.69e-07	1.12e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6—hematologic cancer	4.49e-07	1.08e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYCS—hematologic cancer	4.43e-07	1.06e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.41e-07	1.06e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CB—hematologic cancer	4.41e-07	1.06e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CG—hematologic cancer	4.33e-07	1.04e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CA—hematologic cancer	4.25e-07	1.02e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT1—hematologic cancer	4.15e-07	9.93e-06	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CA—hematologic cancer	4.11e-07	9.85e-06	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CREBBP—hematologic cancer	4.01e-07	9.61e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.91e-07	9.36e-06	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTEN—hematologic cancer	3.81e-07	9.12e-06	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CD—hematologic cancer	3.81e-07	9.12e-06	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALB—hematologic cancer	3.76e-07	9e-06	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CA—hematologic cancer	3.74e-07	8.96e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.7e-07	8.86e-06	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—EP300—hematologic cancer	3.63e-07	8.7e-06	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3R1—hematologic cancer	3.59e-07	8.61e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.59e-07	8.6e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.59e-07	8.6e-06	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKT1—hematologic cancer	3.47e-07	8.32e-06	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKT1—hematologic cancer	3.36e-07	8.05e-06	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CB—hematologic cancer	3.32e-07	7.95e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.17e-07	7.6e-06	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKT1—hematologic cancer	3.06e-07	7.32e-06	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTEN—hematologic cancer	2.87e-07	6.87e-06	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—EP300—hematologic cancer	2.73e-07	6.55e-06	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CA—hematologic cancer	2.69e-07	6.43e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.67e-07	6.39e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.47e-07	5.92e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.34e-07	5.62e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALB—hematologic cancer	2.31e-07	5.54e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.21e-07	5.3e-06	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKT1—hematologic cancer	2.19e-07	5.25e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.04e-07	4.9e-06	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CA—hematologic cancer	2.02e-07	4.84e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTEN—hematologic cancer	1.77e-07	4.23e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—EP300—hematologic cancer	1.68e-07	4.03e-06	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKT1—hematologic cancer	1.65e-07	3.96e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.25e-07	2.98e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKT1—hematologic cancer	1.02e-07	2.44e-06	CbGpPWpGaD
